Consensus document: management of heart failure in type 2 diabetes mellitus
Abstract Type 2 diabetes mellitus (T2DM) is a known predisposing factor for heart failure (HF). The growing burden of these two conditions and their impact on health of the individual and on society in general needs urgent attention from the health care professionals. Availability of multiple treatment choices for managing T2DM and HF may make therapeutic decisions more complex for clinicians. Recent cardiovascular outcome trials of antidiabetic drugs have added very robust evidence to effectively manage subjects with this dual condition. This consensus statement provides the prevalence trends and the impact of this dual burden on patients. In addition, it concisely narrates the types of HF, the different treatment algorithms, and recommendations for physicians to comprehensively manage such patients..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
Heart failure reviews - 26(2020), 5 vom: 24. Mai, Seite 1037-1062 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kaul, Upendra [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: | |
|---|---|
| Themen: |
| Anmerkungen: |
© Springer Science+Business Media, LLC, part of Springer Nature 2020 |
|---|
| doi: |
10.1007/s10741-020-09955-7 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR044652720 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR044652720 | ||
| 003 | DE-627 | ||
| 005 | 20230519234222.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210725s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10741-020-09955-7 |2 doi | |
| 035 | |a (DE-627)SPR044652720 | ||
| 035 | |a (SPR)s10741-020-09955-7-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.85 |2 bkl | ||
| 100 | 1 | |a Kaul, Upendra |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Consensus document: management of heart failure in type 2 diabetes mellitus |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © Springer Science+Business Media, LLC, part of Springer Nature 2020 | ||
| 520 | |a Abstract Type 2 diabetes mellitus (T2DM) is a known predisposing factor for heart failure (HF). The growing burden of these two conditions and their impact on health of the individual and on society in general needs urgent attention from the health care professionals. Availability of multiple treatment choices for managing T2DM and HF may make therapeutic decisions more complex for clinicians. Recent cardiovascular outcome trials of antidiabetic drugs have added very robust evidence to effectively manage subjects with this dual condition. This consensus statement provides the prevalence trends and the impact of this dual burden on patients. In addition, it concisely narrates the types of HF, the different treatment algorithms, and recommendations for physicians to comprehensively manage such patients. | ||
| 650 | 4 | |a Type 2 diabetes mellitus |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Heart failure |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Trials |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Diagnosis |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Drug |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Ray, Saumitra |e verfasserin |4 aut | |
| 700 | 1 | |a Prabhakar, D. |e verfasserin |4 aut | |
| 700 | 1 | |a Kochar, Arun |e verfasserin |4 aut | |
| 700 | 1 | |a Sharma, Kamal |e verfasserin |4 aut | |
| 700 | 1 | |a Hazra, Prakash Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Chandra, Subhash |e verfasserin |4 aut | |
| 700 | 1 | |a Solanki, Dharmesh Ramakant Bhai |e verfasserin |4 aut | |
| 700 | 1 | |a Dutta, Anjan Lal |e verfasserin |4 aut | |
| 700 | 1 | |a Kumar, Viveka |e verfasserin |4 aut | |
| 700 | 1 | |a Rao, M. Srinivas |e verfasserin |4 aut | |
| 700 | 1 | |a Oomman, Abraham |e verfasserin |4 aut | |
| 700 | 1 | |a Dani, Sameer |e verfasserin |4 aut | |
| 700 | 1 | |a Pinto, Brian |e verfasserin |4 aut | |
| 700 | 1 | |a Raghu, T. R. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Heart failure reviews |d Dordrecht [u.a.] : Springer Science + Business Media B.V, 1996 |g 26(2020), 5 vom: 24. Mai, Seite 1037-1062 |w (DE-627)SPR012861839 |w (DE-600)2006431-7 |x 1573-7322 |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2020 |g number:5 |g day:24 |g month:05 |g pages:1037-1062 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s10741-020-09955-7 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.85 |q ASE |
| 951 | |a AR | ||
| 952 | |d 26 |j 2020 |e 5 |b 24 |c 05 |h 1037-1062 | ||